Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease

Shiho Goda, Tadaaki Yamada, Yasuhiro Goto, Sayaka Uda, Akira Nakao, Shinsuke Shiotsu, Yuji Kukida, Keiko Tanimura, Akifumi Miyamoto, Yuki Imasato, Asuka Okada, Isao Hasegawa, Koji Date, Yohei Matsui, Shoki Morito, Noeru Inokuchi, Shuji Osugi, Hayato Kawachi, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Tomohiro Handa, Koichi Takayama

Open source

DOI
10.1186/s12890-026-04347-3
Published
2026-05-19
Container
BMC Pulmonary Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12890-026-04347-3,
  title = {Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease},
  author = {Shiho Goda and Tadaaki Yamada and Yasuhiro Goto and Sayaka Uda and Akira Nakao and Shinsuke Shiotsu and Yuji Kukida and Keiko Tanimura and Akifumi Miyamoto and Yuki Imasato and Asuka Okada and Isao Hasegawa and Koji Date and Yohei Matsui and Shoki Morito and Noeru Inokuchi and Shuji Osugi and Hayato Kawachi and Naoya Nishioka and Masahiro Iwasaku and Shinsaku Tokuda and Tomohiro Handa and Koichi Takayama},
  year = {2026},
  journal = {BMC Pulmonary Medicine},
  doi = {10.1186/s12890-026-04347-3},
  url = {https://doi.org/10.1186/s12890-026-04347-3}
}

RIS

TY  - JOUR
TI  - Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease
AU  - Shiho Goda
AU  - Tadaaki Yamada
AU  - Yasuhiro Goto
AU  - Sayaka Uda
AU  - Akira Nakao
AU  - Shinsuke Shiotsu
AU  - Yuji Kukida
AU  - Keiko Tanimura
AU  - Akifumi Miyamoto
AU  - Yuki Imasato
AU  - Asuka Okada
AU  - Isao Hasegawa
AU  - Koji Date
AU  - Yohei Matsui
AU  - Shoki Morito
AU  - Noeru Inokuchi
AU  - Shuji Osugi
AU  - Hayato Kawachi
AU  - Naoya Nishioka
AU  - Masahiro Iwasaku
AU  - Shinsaku Tokuda
AU  - Tomohiro Handa
AU  - Koichi Takayama
PY  - 2026
JO  - BMC Pulmonary Medicine
DO  - 10.1186/s12890-026-04347-3
UR  - https://doi.org/10.1186/s12890-026-04347-3
ER  - 

APA

Goda, S., Yamada, T., Goto, Y., Uda, S., Nakao, A., Shiotsu, S., Kukida, Y., Tanimura, K., Miyamoto, A., Imasato, Y., Okada, A., Hasegawa, I., Date, K., Matsui, Y., Morito, S., Inokuchi, N., Osugi, S., Kawachi, H., Nishioka, N., Iwasaku, M., Tokuda, S., Handa, T., & Takayama, K. (2026). Baseline neutrophil-to-lymphocyte ratio predicts survival time after the initiation of nintedanib in patients with interstitial lung disease. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-026-04347-3

Source records